Selected article for: "air travel and disease spread"
Author: Fadaka, Adewale Oluwaseun; Sibuyi, Nicole Remaliah Samantha; Adewale, Olusola Bolaji; Bakare, Olalekan Olanrewaju; Akanbi, Musa Oyebowale; Klein, Ashwil; Madiehe, Abram Madimabe; Meyer, Mervin
Title: Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2
  • Cord-id: wrui3i2l
  • Document date: 2020_8_26
    • ID: wrui3i2l
    Snippet: The emergence of coronavirus disease 2019 (COVID-19) in December 2019 has resulted in over 20 million cases and 741,808 deaths globally, affecting more than 200 countries. COVID-19 was declared a pandemic on 11 March 2020 by the World Health Organization. The disease is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). There is limited information on COVID-19, and treatment has so far focused on supportive care and use of repurposed drugs. COVID-19 can be transmitted via pe
    Document: The emergence of coronavirus disease 2019 (COVID-19) in December 2019 has resulted in over 20 million cases and 741,808 deaths globally, affecting more than 200 countries. COVID-19 was declared a pandemic on 11 March 2020 by the World Health Organization. The disease is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). There is limited information on COVID-19, and treatment has so far focused on supportive care and use of repurposed drugs. COVID-19 can be transmitted via person-to-person contact through droplet spread. Some of the recommended precautionary measures to reduce the rate of disease spread include social distancing, good hygiene practices, and avoidance of crowded areas. These measures are effective because the droplets are heavy and can only travel approximately 1 meter in the air, settling quickly on fixed surfaces. Promising strategies to combat SARS-CoV-2 include discovery of therapeutic targets/drugs and vaccines. In this review, we summarize the epidemiology, pathophysiology, and diagnosis of COVID-19. We also address the mechanisms of action of approved repurposed drugs for therapeutic management of the disease.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • abdominal pain and acute inflammatory: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abdominal pain and acute pneumonia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • abdominal pain and adequate treatment: 1, 2, 3
    • abdominal pain and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and low blood pressure: 1
    • abdominal pain and lung consolidation: 1, 2, 3, 4
    • abdominal pain and lung damage: 1
    • abdominal pain and lung disease: 1, 2, 3, 4, 5, 6, 7
    • abdominal pain and lung failure: 1, 2
    • abdominal pain and lung inflammation: 1
    • abdominal pain and lung injury: 1, 2, 3, 4, 5
    • abdominal pain and lung kidney: 1
    • abdominal pain and lung tissue: 1, 2
    • abdominal pain vomiting and acute ards respiratory distress syndrome: 1
    • abdominal pain vomiting and acute inflammatory: 1, 2, 3, 4
    • abdominal pain vomiting and acute pneumonia: 1, 2, 3, 4, 5, 6
    • abdominal pain vomiting and liver kidney: 1, 2, 3, 4, 5
    • abdominal pain vomiting and lung consolidation: 1, 2